Clinical Trial Update: Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating efficacy and safety of chidamide with BEAM pretreatment for autologous transplantation in T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Ruijin Hospital | Conditions: T Cell Lymphoma | Phase 2 | Status: UNKNOWN